Tiragolumab (TIGIT/VSIG9/VSTM3) - Research Grid Biosimilar
Gecertificeerd

Tiragolumab (TIGIT/VSIG9/VSTM3) - Research Grid Biosimilar

Catalog #: 10-856
Maat: 0.1 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100
Technische Documentatie

Technische Specificaties

Background

Tiragolumab is fully humanized monoclonal antibody. Tiragolumab targets TIGIT and directly or indirectly activates anti-tumor immune responses by acting on the activation pathways of APC and T cells and NK cells to achieve the purpose of eliminating tumor cells.

Immunogen

Homo sapiens / TIGIT/VSIG9/VSTM3 [Homo sapiens]

Clonality

• Recombinant Monoclonal

Conjugation

Unconjugated

Type

Primary Antibodies, Biosimilars

Source

CHO cells

Field of Research

Cancer, Immunology

Purification

>95%

Concentration

Batch dependent

Buffer

PBS buffer pH7.5

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.

Fragment

IgG1-kappa

NCBI Organism

Homo sapiens

Other Product Names

MTIG-7192-A, MTIG-7192A, MTIG7192A, RG-6058, RO-7092284, RO7092284

Beschrijving

Tiragolumab (TIGIT/VSIG9/VSTM3) - Research Grid Biosimilar Beschikbaar in 0.1 mg. Bestel eenvoudig online met snelle levering.

Specificaties

ProductnaamTiragolumab (TIGIT/VSIG9/VSTM3) - Research Grid Biosimilar
Categorie
Beschikbare grootte0.1 mg
Catalogusnummer10-856